The Alcohol and Drug Awareness Council (ADAC) in Lufkin is set to lose roughly $400,000 in grants and state funding, ...
Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata” or the "Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...
GoodRx Holdings, Inc. ( GDRX) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Third Quarter 2025 Earnings Call. As a ...
Q3 2025 Earnings Call November 10, 2025 5:00 PM ESTCompany ParticipantsKirsten Newquist - CEO & DirectorEdward Kirnbauer - ...
Inclusion in the ENDO 1000 study in the UK for multiple sample types is presented as evidence of market validation for OraSure Technologies' collection kits, as described in the Q3 2025 earnings call, ...
Selected lead candidates AL137 for the company’s Alector Brain Carrier (ABC)-enabled anti-amyloid beta antibody in Alzheimer's disease, and AL050 for its ABC-enabled GCase enzyme replacement therapy ...
This article provides insights into patterns of health care use following emergency department visits by high-need, high-cost patients with different types of California Medicaid primary care ...
Opinion
Sentinel & Enterprise on MSNOpinion

Editorial: DOC programs significantly lower reoffending rates

The state’s correctional system seems intent on putting itself out of business. The maximum-security MCI-Cedar Junction facility in Walpole closed in 2023, while in 2024, both the medium-security ...
Palvella’s recently expanded rare disease pipeline now comprises QTORIN™-derived product candidates advancing in four serious ...
The “Alpha Arena” pits the six most popular artificial intelligence programs in a crypto-trading competition to see which is independently smart enough to master the market and ...
Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...
The Foundation for Opioid Response Efforts (FORE) today announced five new grants totaling more than $2 million to support collaborative strategies addressing the nation’s opioid and overdose crisis.